Previously, the National Institute on Aging and Alzheimer’s Association classified the biomarkers of AD into A (amyloid), T (phosphorylated tau), and N (neurodegeneration): the ATN framework [2]. The gene discussed is MAPT; the disease is Alzheimer disease.